Azerbaijan National Academy of Sciences

The DPRK has developed a candidate vaccine against COVID-19, according to the North Korean research portal Mire (Future).

According to the portal, scientists at the Center for Medicine Research of the Institute for the Study of Medicine and Biology have developed a recombinant subunit vaccine based on the genetic sequence data of the spike S-protein from the membrane of the coronavirus, which binds to the human angiotensin-converting enzyme 2 (ACE2) in our cell membranes, thus attaching to cage.

The vaccine has been proven safe and effective in animals, and clinical trials have begun in early July. “Considering that there is not a single coronavirus patient in the DPRK, it is now being discussed how to conduct the third stage of clinical trials,” the portal notes.

www.world.kbs.co.kr